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Abstract
Multivariate linear mixed models (mvLMMs) have been widely used in many areas of genet-
ics, and have attracted considerable recent interest in genome-wide association studies (GWASs).
However, fitting mvLMMs is computationally non-trivial, and no existing method is computa-
tionally practical for performing the likelihood ratio test (LRT) for mvLMMs in GWAS settings
with moderate sample size n. The existing software MTMM [1] perform an approximate LRT
for two phenotypes, and as we find, its p values can substantially understate the significance of
associations. Here, we present novel computationally-efficient algorithms for fitting mvLMMs,
and computing the LRT in GWAS settings. After a single initial eigen-decomposition (with
complexity O(n3)) the algorithms i) reduce computational complexity (per iteration of the op-
timizer) from cubic to linear in n; and ii) in GWAS analyses, reduces per-marker complexity
from cubic to quadratic in n. These innovations make it practical to compute the LRT for
mvLMMs in GWASs for tens of thousands of samples and a moderate number of phenotypes
(∼ 2 − 10). With simulations, we show that the LRT provides correct control for type I er-
ror. With both simulations and real data we find that the LRT is more powerful than the
approximate LRT from MTMM, and illustrate the benefits of analyzing more than two phe-
notypes. The method is implemented in the GEMMA software package, freely available at
http://stephenslab.uchicago.edu/software.html.
Introduction
Multivariate linear mixed models (mvLMMs) [2] have been applied to many areas of genetics,
including, for example, estimating the cross-tissue heritability of gene expression [3], assessing the
pleiotropy and genetic correlation between complex phenotypes [1, 4, 5, 6], detecting quantitative
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trait loci [7], understanding evolutionary patterns [8] and assisting animal breeding programs [9].
Recently, these models have become increasingly important in genome-wide association studies
(GWASs), not only because of their demonstrated effectiveness in accounting for sample relatedness
[10, 7, 1] and in controlling for population stratification [1] (as for their univariate counterparts
[11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21]), but also because of a growing appreciation of the potential
gains in power from multivariate association analyses [22, 23, 24, 25, 26, 27, 1, 28]. Indeed, [28]
emphasizes that, compared with standard univariate analyses, multivariate analyses can increase
power not only to detect pleiotropic genetic variants that affect multiple phenotypes simultaneously,
but also genetic variants that affect only one of a collection of correlated phenotypes.
However, fitting mvLMMs is computationally non-trivial, involving a multi-dimensional opti-
mization for a potentially non-convex function (either the likelihood or the restricted likelihood).
These computational challenges become very substantial when applying mvLMMs to GWASs: for
example, performing the likelihood ratio test (LRT) for association with each SNP requires these
optimizations to be performed repeatedly for hundreds of thousands of SNPs in turn. Consequently
no existing method is computationally practical for performing the LRT for mvLMMs in GWAS
settings. The only available method along these lines (MTMM [1]) can perform only an approx-
imate LRT, and only for two phenotypes. Furthermore, as we will show later, the p values from
this approximation are not well calibrated under the null hypothesis, at least in settings involving
strongly related individuals, and can substantially understate the significance of associations.
Here, we present a novel computationally-efficient algorithm, and a software implementation,
for fitting mvLMMs with one covariance component (in addition to the residual error term), and for
performing the LRT of association in GWASs. The algorithm builds on linear algebra techniques
previously used for univariate LMMs [17, 18, 19], and, combined with several additional tricks,
extends them to multivariate LMMs. In effect, our algorithms provide the multivariate analogues
of the univariate algorithms EMMA [14] and FaSTLMM/GEMMA/CM [17, 18, 19]. Our algorithms
provide the first computationally-practical approach to computing LRTs for mvLMMs in GWAS
with a reasonably large number of individuals (e.g. 50,000), and for a modest number of phenotypes
(e.g. 2-10).
Results
Model and method overview
We consider the multivariate linear mixed model [2],
Y = AW + βxT + G + E; G ∼ MNd×n(0,Vg,K), E ∼ MNd×n(0,Ve, In×n), (1)
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where n is the number of individuals, d is the number of phenotypes, Y is a d by n matrix of
phenotypes, W is a c by n matrix of covariates including a row of 1s as intercept and A is a d
by c matrix of corresponding coefficients, x is a n-vector of genotypes for a particular marker and
β is a d-vector of its effect sizes for the d phenotypes, G is a d by n matrix of random effects,
E is a d by n matrix of residual errors, K is a known n by n relatedness matrix, In×n is the n
by n identity matrix, Vg is a d by d symmetric matrix of genetic variance component, Ve is a d
by d symmetric matrix of environmental variance component and MNd×n(0,V1,V2) denotes the
d × n matrix normal distribution with mean 0, row covariance matrix V1 (d by d), and column
covariance matrix V2 (n by n).
We have developed efficient algorithms for applying mvLMMs to GWASs. Specifically, for each
genetic marker in turn, the algorithms perform the LRT comparing the null hypothesis that the
marker effect sizes for all phenotypes are zero, H0 : β = 0, where 0 is a d-vector of zeros, against
the general alternative H1 : β 6= 0. Our algorithms provide the first computationally-practical
approach to computing this LRT for GWAS, and our software is the only available implementation
for computing mvLMM test statistics of any kind in GWAS with more than 2 phenotypes.
The LRT requires maximum likelihood estimates for parameters Vg,Ve,A and β under both
H0 and H1. Current algorithms for obtaining these estimates (implemented in software GCTA
[29, 4], WOMBAT [30], ASREML [31]) all use similar approaches with the same computational
complexity. Specifically, the methods combine two types of optimization algorithm: an initial
Expectation-Maximisation-like (EM) algorithm, followed by a Newton-Raphson-like (NR) algo-
rithm. This combines the benefits of the stability of the EM-like algorithm (every iteration increases
the likelihood) with the faster convergence of the NR-like algorithm ([32]; Supplementary Note and
Figure S1). The computational complexity of these existing methods is O(t1n
3d3 + t2n
3d7) where
t1, t2 are the maximum number of iterations used for EM and NR optimizers respectively (Sup-
plementary Note). To apply these to GWAS would require this procedure to be repeated for all
s SNPs, with resulting computational complexity O(s(t1n
3d3 + t2n
3d7)). This is computationally
impractical for GWAS with large s and moderate n (see below).
In comparison, our algorithms very substantially reduce the computational burden of computing
LRTs for GWAS, by using linear algebra tricks to avoid repeating the expensive O(n3) operations
for every SNP. Specifically, after an initial single O(n3) operation (eigen-decomposition of the
relatedness matrix K), our algorithms have per-SNP complexity that increases only quadratically
in n. The overall computational complexity is O(n3 + n2d+ s(n2 + t1nd
2 + t2nd
6)). In effect, our
algorithms (detailed in Supplementary Note) provide the multivariate analogue of the univariate
algorithms EMMA [14], and FaSTLMM/GEMMA/CM [17, 18, 19].
We implemented the algorithms in the GEMMA software package [18, 21], freely available at
http://stephenslab.uchicago.edu/software.html.
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Table 1: Comparison of computation time of different methods for parameter estimation in a
single mvLMM. Results are shown for both HMDP and NFBC1966 data sets. All computing was
performed on a single core of an Intel Xeon L5420 2.50GHz CPU. In all cases the three packages
give numerically identical results, both for estimated variance components and their standard errors
(data not shown). n is the number of individuals, d is the number of traits, c is the number of
covariates (c = 1 here), t1 is the number of iterations used in the EM type algorithm and t2 is the
number of iterations used in the NR type algorithm. The implementation of GCTA does not handle
more than two traits. The comparison also favors the other two software because of the much more
stringent stopping criteria used in GEMMA: t1 in GEMMA is often two orders of magnitude larger
than that used in the other two software, while t2 in GEMMA is similar to that used in the other
two. The n3 step in GEMMA could be replaced with a mn2 step [14] for the HMDP data, where
m is the number of strains. Notice that the compute time for GEMMA is essentially the same for
all d, because in GEMMA the compute time is dominated by the initial O(n3) eigen-decomposition
step; the following optimization iterations are negligible.
Method Time Complexity
Computation Time
HMDP NFBC1966
(n = 656) (n = 5255)
d = 2 d = 3 d = 4 d = 2 d = 3 d = 4
GEMMA O(n3 + n2d+ n2c+ t1nc
2d2 + t2nc
2d6) < 1.0 s < 1.0 s < 1.0 s 6.7 min 6.7 min 6.7 min
WOMBAT O(t1n
3(d+ c)3 + t2n
3d7) 12.5 s 39.2 s 71.0 s 31.0 min 127.6 min 477.3 min
GCTA O(t1n
3(d+ c)3 + t2n
3d7) 11.2 s – – 38.2 min – –
Comparisons with existing methods
To illustrate the benefits of our new algorithms we used two data sets: a mouse GWAS from the
Hybrid Mouse Diversity Panel (HMDP) with four blood lipid phenotypes (high-density lipopro-
tein, HDL; total cholesterol, TC; triglycerides, TG; unesterified cholesterol, UC), and a human
GWAS from the Northern Finland Birth Cohort 1966 (NFBC1966) with four blood metabolic
traits (high-density lipoprotein, HDL; low-density lipoprotein, LDL; triglycerides, TG; C-reactive
protein, CRP). The HMDP data are a small GWAS (n = 656) with strong relatedness among many
individuals; the NFBC1966 data are a larger GWAS (n = 5, 255) with weak relatedness among most
individuals.
Even for fitting a single mvLMM, our algorithms have lower computational complexity than
existing algorithms. Indeed, for these data our implementation in GEMMA is substantially (5-71
times) faster than implementations of existing algorithms in software GCTA and WOMBAT (Table
1). For example, for the NFBC1966 data, with d = 4, GEMMA takes about 7 minutes compared
with 8 hours for WOMBAT. The gains for larger d would be even greater.
However, the more practically-important gains of our new algorithms come in GWAS applica-
tions. Here, no existing algorithm is practical for computing the LRT for even d = 2. Extrapolating
from Table 1 suggests that existing algorithms, if implemented in software, might take over 14 days
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for HMDP and over 18 years for NFBC1966. As far as we are aware, the only current practical
competitor for our method is a method implemented in software MTMM [1], which uses an approx-
imation to the LRT [33, 15, 16] to reduce per-SNP computation time to quadratic in n. Specifically,
this approximate LRT avoids the expensive repeated optimization of the variance components un-
der H1 for each SNP, by re-using part of the pre-estimated variance components under H0 (fit using
the software ASREML). However, this approximate LRT is guaranteed to underestimate the LRT
(Supplementary Note), and in the univariate setting this has been shown to produce mis-calibrated
p values and/or loss of power for data sets involving smaller numbers of individuals and strong
relatedness [18, 19].
To illustrate this in the multivariate setting we performed null and alternative simulations
using the HMDP data (Online Methods). Consistent with the univariate findings, MTMM p values
are systematically larger than expected under the null, with the most significant p values being
almost an order of magnitude larger than expected (Figure 1a). In contrast, p values from the
GEMMA LRT are well-calibrated (Figure 1a). This demonstrates that, despite the fact that the
mvLMM likelihood surface could be non-convex, with multiple local optima, any problems that
our optimization methods have with local maxima have minimal practical impact. (We found
that obtaining well-calibrated p values requires both the EM and NR algorithms: use of only the
EM algorithm can lead to poor convergence of the LRT, and resulting in underestimation of p
values similar to MTMM; Figure S1) The systematic inflation of MTMM’s p values under the null
presumably accounts for MTMM’s loss of power relative to GEMMA in simulations under the
alternative (Figure 1b).
In addition to these simulations, we also compared GEMMA and MTMM on the real HMDP
and NFBC1966 datasets. Since MTMM is implemented only for d = 2, we analyzed all pairs of
traits. For these data, GEMMA ran 2-12 times faster than MTMM (Table 2). In particular, in the
NFBC1966 data, GEMMA takes about four hours to finish a two-phenotype mvLMM analysis that
takes MTMM almost two and a half days. (In fact, GEMMA can finish the multivariate analysis
for four traits within six hours.) Consistent with the simulations, and with theory, the MTMM
p values for HMDP are consistently less significant (up to 6 fold less significant) than p values
from GEMMA (Figure 1c). For NFBC1966 the two methods produce similar p values (Figure 1d),
consistent with univariate assessments that show the approximation used in MTMM to work well
when, as in NFBC1966, the sample size is large, individuals are not closely related and the marker
effect size is small.
Analyzing more than two phenotypes
Our methods and software also make possible, for the first time, GWAS analysis using mvLMMs
with more than two phenotypes. The use of multivariate association analyses in GWAS has been the
subject of considerable recent interest [22, 23, 24, 25, 26, 27, 1, 28], and many studies have demon-
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Table 2: Computation time for GWAS analysis with mvLMM using different methods for the HMDP
and NFBC1966 data sets. All computing was performed on a single core of an Intel Xeon L5420
2.50GHz CPU. The computing time for MTMM only include the multiplication of the genotype
matrix with an nd by nd matrix, and does not include the time spent fitting the null model (because
MTMM relies on the commercial software ASREML to do so), nor the time spent reading/writing
files and inverting the nd by nd matrix. The computing time for GEMMA include all steps. n is
the number of individuals, s is the number of SNPs, d is the number of traits, c is the number of
covariates (c = 1 here), t1 is the number of iterations used in the EM type algorithm and t2 is the
number of iterations used in the NR type algorithm. The MTMM software implementation handles
only two traits. The pn2 step in GEMMA could be replaced with a pnr step if the relatedness matrix
is of rank r.
Method Time Complexity
Computation Time
HMDP NFBC1966
(n = 656, s = 108, 562) (n = 5255, s = 319, 111)
d = 2 d = 3 d = 4 d = 2 d = 3 d = 4
GEMMA O(n3 + n2d+ n2c+ s(n2 + t1nc
2d2 + t2nc
2d6)) 6.2 min 13.7 min 28.5 min 4.4 h 4.8 h 5.8 h
MTMM O(t1n
3(d+ c)3 + t2n
3d7 + sn2d2) 16.4 min – – 58.0 h – –
strated the potential gain in power of multivariate vs univariate analyses [22, 23, 24, 25, 26, 27, 1, 28].
However, multivariate analyses also raise their own challenges, not least that a significant result
in a multivariate test does not immediately indicate which phenotypes are driving the association.
These issues are discussed in detail in [28], which outlines a framework for multivariate associa-
tion analysis based on model comparison, rather than testing. This framework also clarifies under
which situations various multivariate tests may be more or less powerful than univariate tests,
and provides guidance on how to integrate results from multiple association tests (e.g. from both
univariate and multivariate tests). Our work here lays the foundations for using this framework
with mvLMMs; specifically, our maximum likelihood algorithms could be used to approximate (e.g.
via Laplace approximation) the Bayes Factors that are required to implement the framework in
practice. However, this lies outside the scope of this paper, and instead we simply illustrate via
simulations and real data analysis the potential power gains of multivariate analysis.
Figure S2a and S2b shows results of simulations, based on both HDMP and NFBC1966 data,
comparing power of the multivariate LRT of all four phenotypes vs conducting all six two-phenotype
analyses and applying a Bonferroni correction for the six tests performed. In these simulations
the four-phenotype analysis is consistently more powerful (or as powerful) as the two-phenotype
analyses, even when only one or two of the four phenotypes are truly associated with genotype.
(Without Bonforroni correction the two-phenotype analysis is slightly more powerful for two out
of eight simulations, and less powerful for the other six; Figure S2c and S2d.) While it may seem
counter-intuitive that a four-phenotype analysis is more powerful than a two-phenotype analysis
6
even when exactly two phenotypes are associated with genotype, this is actually expected, for rea-
sons discussed in [28]: including unassociated phenotypes in the multivariate analysis can increase
power if these unassociated phenotypes are correlated with the associated phenotypes.
We also applied four-phenotype, two-phenotype, and univariate analyses to the NFBC1966
data. In total, 45 SNPs from 14 genetic regions pass a significance level of 0.05 after Bonferroni
correction (both for the number of SNPs and, in univariate and two-phenotype analyses, for the
number of tests) in either the four-phenotype, two-phenotype, or univariate analyses. As expected,
some SNPs show stronger signals in the four-phenotype analysis, whereas others show stronger
signals in a two-phenotype or univariate analysis. Comparing the four-phenotype analysis with the
univariate analysis (Table S1), 16 SNPs were significant in the four-phenotype analysis and not the
univariate analysis; whereas 3 SNPs were significant only in the univariate analysis. Comparing
the four-phenotype analysis with the two-phenotype analysis (Table S2), 1 SNP was significant in
the four-phenotype analysis and not the two-phenotype analysis, whereas no SNP was significant
only in the two-phenotype analysis.
These simulation and real-data results are consistent with the idea that multivariate tests will
often provide more power than multiple univariate or pairwise tests. However, it is also clear that in
a GWAS setting no single test will be the most powerful to detect the many different types of genetic
effects that could occur. Indeed, as in [28], it should be possible to manufacture simulations so that
any given test is the most powerful. Therefore we prefer to emphasize that different multivariate
and univariate tests can be complementary to one another, rather than competing.
Missing phenotype imputation
One limitation of our algorithms is that they require fully observed phenotypes. Since in a typi-
cal study many individuals may have partially missing phenotypes, removing all such individuals
could substantially reduce power. To address this we developed a phenotype imputation scheme for
mvLMMs (Supplementary Note), which can be applied to impute missing phenotypes before apply-
ing our LRT methods. In brief, the imputation method first estimates parameters of the mvLMM
under the null model using individuals with fully observed phenotypes, and then, conditional on
these estimates and the observed phenotype data, imputes missing phenotypes using their condi-
tional means. Figure S3 shows the results of simulations, based on both HMDP and NFBC1966
data, comparing the power of this imputation-based approach with the alternative approach of
dropping individuals with partially missing phenotypes. For the HMDP simulations, because of
the high relatedness, both methods achieve almost identical power as if all phenotypes are fully
observed. For the NFBC1966 data, phenotype imputation achieves consistently greater power than
dropping individuals, and in many simulation scenarios achieves power similar to that achieved if
all phenotypes are observed (0% missingness in Figure S3).
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Discussion
Here, we present novel algorithms, and a software implementation in the package GEMMA, for
multivariate analysis using mvLMMs in genetic association studies. This method is the first
computationally-practical method for computing the LRT for the mvLMMs in GWAS applications,
and the first software implementation of any kind of test for GWAS with more than two phenotypes.
Through simulation, we demonstrated that the p values from our test are well-calibrated under the
null, unlike p values from existing methods based on an approximation to the LRT.
Our algorithms are not without their limitations. Perhaps the most fundamental is that, like its
univariate counter-parts, our algorithms only apply to mvLMMs with one variance component (in
addition to the residual error term). However, additional assumptions may allow our algorithms to
be extended to allow for more variance components [34]. In addition, although our implementation
of the EM algorithm scales only quadratically with the number of phenotypes, d, and so could be
applied to reasonably large d, in practice we caution that there could remain both computational
and statistical barriers to applying these methods to even quite modest values of d (e.g. d ≈ 10).
Computationally, the number of iterations required to converge for larger d will inevitably increase,
and ultimately this issue could be the main barrier to effectively maximizing the likelihood for
large d. Statistically, the number of parameters in the mvLMM is also quadratic in the number
of phenotypes (the number of parameters in the two variance components is d(d+ 1)). Therefore,
with a moderate sample size, additional assumptions on the structure of the variance components
may be necessary to obtain reliable estimates. For example, one could penalize the departure of the
estimated variance components to some prior values [35], or could assume the variance components
are of low rank [36] or sparse [37]. The effectiveness of such strategies, paired with the mvLMM,
in GWASs is a topic for potential further research.
The most computationally expensive part of our method, as in the univariate case, is the
eigen-decomposition step. (Although the genotype transformation step can be expensive with a
large number of markers, it can be easily parallelized in a computing cluster.) The initial eigen-
decomposition step not only requires a large amount of physical memory, but also becomes com-
putationally intractable in practice, for large n (e.g. > 50, 000 [38]). Low rank approximations to
the relatedness matrix [17, 39, 18] can alleviate both computation and memory requirements, and
using these kinds of methods mvLMMs could be applied to very large GWASs.
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(a) HMDP-based simulations, Type I Error (b) HMDP-based simulations, Power
(c) HMDP (d) NFBC1966
Figure 1: GEMMA versus MTMM. (a) Comparison of type I error control with simulations based on
the HMDP data. QQ-plot of observed versus expected -log10 p values under the null, for GEMMA
(red) and MTMM (blue). Gray shaded area indicates 0.025 and 0.975 point-wise quantiles of the
ordered p values under the null distribution. (b) Comparison of power for GEMMA (red) and
MTMM (blue), at a nominal p value threshold of 4.6× 10−7, in four different simulation scenarios
based on the HMDP data. x-axis in shows the proportion of phenotypic variance in the first
phenotype explained (PVE) by the SNP, while the point symbol and line type indicate the SNP
effect direction (compared with its effect on the first phenotype) and size (quantified by PVE) on
the second phenotype (+: opposite direction, 0.8PVE; ×: opposite direction, 0.2PVE; o: same
direction, 0.8PVE; ∆: same direction, 0.2PVE). Comparison of -log10 p values for (c) paired traits
HDL-TG in the HMDP data and (d) paired traits HDL-TG in the NFBC1966 data.
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Methods
Genotype and Phenotype Data
We analyzed two data sets: the Hybrid Mouse Diversity Panel (HMDP) [40] and the Northern
Finland Birth Cohort 1966 (NFBC1966) Study [41].
The HMDP data includes 100 inbred strains with four phenotypes (high-density lipoprotein,
HDL; total cholesterol, TC; triglycerides, TG; unesterified cholesterol, UC) and four million high
quality fully imputed SNPs (SNPs are downloaded from http://mouse.cs.ucla.edu/mousehapmap/
full.html). We excluded mice with missing phenotypes for any of these four phenotypes. We ex-
cluded non-polymorphic SNPs, and SNPs with a minor allele frequency less than 5%. For SNPs
that have identical genotypes, we tried to retain only one of them (by using “–indep-pairwise 100 5
0.999999” option in PLINK [42]). This left us with 98 strains, 656 individuals and 108,562 SNPs.
We quantile transformed each phenotype to a standard normal distribution to guard against model
mis-specification. We used the product of centered genotype matrix as an estimate of relatedness
[43, 44, 21]. Note that the sample size used here is smaller than the original study [40], and the
phenotypes are quantile-transformed instead of log transformed for robustness.
The NFBC1966 data contains 5402 individuals with multiple metabolic traits measured and
364,590 SNPs typed. We selected four phenotypes (high-density lipoprotein, HDL; low-density
lipoprotein, LDL; triglycerides, TG; C-reactive protein, CRP) among them, following previous
studies [1]. We selected individuals and SNPs following previous studies [41, 16] with the software
PLINK [42]. Specifically, we excluded individuals with missing phenotypes for any of these four
phenotypes or having discrepancies between reported sex and sex determined from the X chromo-
some. We excluded SNPs with a minor allele frequency less than 1%, having missing values in
more than 1% of the individuals, or with a Hardy-Weinberg equilibrium p value below 0.0001. This
left us with 5,255 individuals and 319,111 SNPs. For each phenotype, we quantile transformed
the phenotypic values to a standard normal distribution, regressed out sex, oral contraceptives and
pregnancy status effects [41], and quantile transformed the residuals to a standard normal distribu-
tion again. We replaced the missing genotypes for a given SNP with its mean genotype value. We
used the product of centered and scaled genotype matrix as an estimate of relatedness [43, 44, 16].
In both data sets, we quantile transformed each single phenotype to a standard normal distri-
bution to guard against model misspecification. Although this strategy does not guarantee that
the transformed phenotypes follow a multivariate normal distribution jointly, it often works well
in practice when the number of phenotypes is small (see, e.g. [28]). For both data sets, we used
a standard mvLMM with an intercept term (without any other covariates), and test each SNP in
turn. Because the software MTMM relies on the commercial software ASREML to estimate the
variance components in the null model, we modified the MTMM source code so that it can read in
the estimated variance components from GEMMA.
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Simulations
To check if GEMMA and MTMM produce calibrated p values, we used real genotypes in the HMDP
data and simulated phenotypes under the null. Specifically, we simulated 10,000 null phenotypes
based on the real relatedness matrix and the two estimated variance components (for HDL and
TG), and calculated p values for each SNP-phenotype pair (approximately 1 trillion pairs) in turn.
We did not perform comparisons based on the NFBC1966 data, partly because GEMMA and
MTMM produce identical p values there, and partly because the sample size in NFBC1966 makes
it computationally impractical to perform trillions of association tests to check for the type I error
at the genome-wide significance level.
To compare power between GEMMA and MTMM, we used real genotypes from the HMDP
and NFBC1966 data, and we simulated phenotypes by adding genotype effects back to the original
phenotypes [15, 18]. Specifically, we first identified SNPs unassociated with the four phenotypes
based on one-phenotype, two-phenotype and four-phenotype analyses (LRT p value > 0.1 in any of
the 11 tests). We ordered the SNPs (76,780 in HMDP and 208,145 in NFBC1966) satisfying this
criteria by their genomic location, and selected from them 10,000 evenly spaced SNPs to act as
causal SNPs. For each causal SNP, we specified its effect size for the first trait (HDL) to explain
a particular percentage of the phenotypic variance (proportion of variance explained, or PVE).
Afterwards, we specified its effect for the second trait (TG) so that the proportion of variance
in the second trait explained by the SNP equals to either 20% or 80% of the PVE in the first
trait. We considered effect sizes for the two traits to be either in the same direction or in the
opposite directions, and we added the simulated effects back to the original phenotypes to form
the new simulated phenotypes. For each pre-specified PVE (ranged from 2% to 20% in HMDP
and 0.04% to 0.4% in NFBC1966), we simulated 10000 sets of phenotypes, one for each causal
SNP, and calculated p values for each SNP-phenotype pair. We calculated statistical power as the
proportion of p values exceeding the genome-wide significance level at the conventional 0.05 level
after Bonferroni correction (p = 4.6× 10−7 for HDMP and p = 1.6× 10−7 for NFBC1966). Notice
that we simulated phenotypes based on HDL and TG in both data sets, and the two phenotypes
are positively correlated in HMDP but negatively correlated in NFBC1966.
Our algorithms rely on fully observed phenotypes, and when missing phenotypes are present, we
have to either drop individuals with partially missing phenotypes, or impute these missing values.
To compare power between the two approaches (imputation versus dropping), we used the same set
of simulated phenotypes described above, but randomly made 2.5%, 5% or 10% of the individuals
to have one phenotype missing. We calculated p values for each SNP-phenotype pair from the two
approaches using GEMMA, and calculated statistical power at the conventional 0.05 level after
Bonferroni correction.
Finally, we performed a power comparison between the four-phenotype analysis and the two-
phenotype analysis using GEMMA, with simulations based on the two data sets. Specifically,
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we used the same set of 10,000 SNPs described above to act as causal SNPs, and we simulated
phenotypes by adding genotype effects to the observed phenotypes, as above. For each causal SNPs,
we made it to affect either one, two, three or four phenotypes. When the causal SNP affected two
or four phenotypes, its effects on randomly selected half of the traits were in the opposite direction
as that on the other half. When the causal SNP affected three phenotypes, its effects on randomly
selected two traits were in the opposite direction as that on the third trait. The SNP effect size
for each affected phenotype was simulated independently to account for a pre-specified PVE of
that phenotype (ranged from 0.5% to 5% in HMDP and 0.04% to 0.4% in NFBC1966), which was
further scaled with a random factor draw from a uniform distribution U(0.8, 1). The simulated
effects were added back to the original phenotypes to form the new simulated phenotypes. For the
four-phenotype analysis, we calculated p values for each SNP-phenotype pair and we calculated
statistical power at the conventional 0.05 level after Bonferroni correction (p = 4.6 × 10−7 for
HDMP and p = 1.6 × 10−7 for NFBC1966). For the two-phenotype analysis, we obtained the
minimal p value from the six pair-wise analyses for each SNP, and calculated statistical power as
the proportion of these p values exceeding either the same significance level (p = 4.6 × 10−7 for
HDMP and p = 1.6 × 10−7 for NFBC1966), or a significance level that was further adjusted to
account for the six tests performed (p = 7.6× 10−8 for HDMP and p = 2.6× 10−8 for NFBC1966).
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1 Supplementary Note
1.1 Multivariate Linear Mixed Model
We consider the multivariate linear mixed model [2],
Y˜ = AW˜ + βx˜T + G˜ + E˜; G˜ ∼ MNd×n(0,Vg,K), E˜ ∼ MNd×n(0,Ve, In×n), (2)
where n is the number of individuals, d is the number of phenotypes, Y˜ is a d by n matrix of
phenotypes, W˜ is a c by n matrix of covariates including a row of 1s as intercept and A is a d
by c matrix of corresponding coefficients, x˜ is a n-vector of genotype for a particular marker and
β is a d-vector of its effect sizes for the d phenotypes, G˜ is a d by n matrix of random effects, E˜
is a d by n matrix of residual errors, K is a known n by n relatedness matrix, In×n is a n by n
identity matrix, Vg is a d by d symmetric matrix of genetic variance component, Ve is a d by d
symmetric matrix of environmental variance component and MNd×n(0,V1,V2) denotes the d× n
matrix normal distribution with mean 0, row covariance matrix V1 (d by d), and column covariance
matrix V2 (n by n).
We group all covariates together into a (c+1) by n matrix X˜ =
(
W˜
x˜T
)
, and group all coefficients
together into a d by (c+ 1) matrix B = (A,β).
Following [17, 18, 19], we perform an eigen-decomposition of the relatedness matrix K =
UkDkU
T
k , where Uk is a n by n matrix of eigen vectors and Dk is a diagonal n by n matrix
filled with the corresponding eigen values, or diag(δ1, · · · , δn). We then obtain transformed pheno-
type matrix Y = Y˜Uk and transformed covariate matrix X = X˜Uk. We further denote G = G˜Uk
as the transformed random effect matrix, and E = E˜Uk as the transformed residual error matrix.
Now, the transformed phenotypes given the transformed covariates follow
Y = BX + G + E; G ∼ MN(0,Vg,Dk), E ∼ MN(0,Ve, In×n), (3)
which is equivalent to
y = XT ⊗ Id×db + g + e; g ∼ MVN(0,Dk ⊗Vg), e ∼ MVN(0, In×n ⊗Ve), (4)
where y = vec(Y), b = vec(B), g = vec(G), e = vec(E), vec denotes vectorization (i.e. stacking
columns), MVN denotes multivariate normal distribution and ⊗ denotes Kronecker product.
Therefore, for each individual l, the transformed phenotypes given the transformed covariates
follow independent (but not identical) multivariate normal distributions
yl = Bxl + gl + el; gl ∼ MVN(0, δlVg), el ∼ MVN(0,Ve), (5)
13
with variance Vl = δlVg + Ve, where yl is the lth column vector of Y, xl is lth column vector of
X, gl is lth column vector of G, el is lth column vector of E, ∀l = 1, · · · , n.
1.2 Optimization Method Overview
We are interested in obtaining parameter estimates from this model, which are used further to obtain
statistics and p values to test the null hypothesis that the marker effect sizes for all phenotypes are
zero, H0 : β = 0, where 0 is a d-vector of zeros, against the general alternative H1 : β 6= 0. This
test, in the bivariate case, corresponds to the “full test” in MTMM. We do not consider either the
“interaction test” or the “common test” in MTMM here.
Parameter estimation in a mvLMM presents substantial computational challenges, in part be-
cause it requires multi-dimensional optimization for a potentially non-convex function. Procedures
for multi-dimensional optimization can be classified into two categories based on whether or not
they use derivatives. Derivative-free methods evaluate the (restricted) likelihood function for every
combination of parameters along a searching path [45, 46, 10]. They are easy to implement, but
are often computationally inefficient: their time complexity grows exponentially with the number
of parameters, making them impractical for a reasonably large number of phenotypes [47]. (For
instance, the original paper on the derivative-free method for mvLMM only showed examples for
two phenotypes [10].) The derivative-based methods include the expectation maximization (EM)
algorithm [48] and its accelerated version using parameter expansion (PX-EM) [49, 50]; and the
Newton-Raphson (NR) algorithm [51, 52] and its variant, the average information (AI) algorithm
[31]. Because of the stability of EM-type algorithms (each iteration is guaranteed to increase the
likelihood), and the faster convergence rate of NR-type algorithms, the two are often combined to
gain the benefits of both (e.g. PX-AI algorithm) [32]. This strategy is used in many existing soft-
ware packages, including the free packages GCTA [29, 4], and WOMBAT [30], and the commercial
package ASREML [31].
Unfortunately, even with the PX-AI algorithm, the per-iteration computation time for fitting a
mvLMM still increases cubically, or worse, both with the number of individuals (n) and with the
number of phenotypes (d) (the computational complexity is O(n3d3) for EM and O(n3d7) for AI).
This is because existing method require repeated “inversion” (actually, solving a system of linear
equations) of an nd × nd matrix, in every iteration of the EM-like algorithm, and for evaluating
every element inside the average information matrix (which is a d(d+1) by d(d+1) matrix) during
each iteration of the NR-like algorithm, a computationally expensive procedure which increases
cubically with both n and d (O(n3d3)). This becomes especially problematic in GWASs where the
optimizations are performed for every SNP in turn. To address this issue, [1] recently introduced
the multi-trait mixed model (MTMM) method [1], implemented in the MTMM software, to use
an approximation strategy [33, 15, 16] to reduce computation time from cubic to quadratic in n.
Specifically, the approximation avoids repeatedly re-optimizing the variance components under the
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alternative model for each SNP, by re-using part of the pre-estimated variance components under the
null model (fit using the software ASREML) to approximate the likelihood ratio statistic. However,
the approximated likelihood ratio statistic 2l1(β˜1, θ˜
′
1, θˆ0)−2l0(θˆ
′
0, θˆ0) is guaranteed to be less than
the true likelihood ratio statistic 2l1(βˆ1, θˆ
′
1, θˆ1) − 2l0(θˆ
′
0, θˆ0), since l1(β˜1, θ˜
′
1, θˆ0) < l1(βˆ1, θˆ
′
1, θˆ1),
where θ are the variance component parameters to be fixed from H0, θ
′ are the variance component
parameters to be estimated from H1, θˆ, θˆ
′
and βˆ are MLE estimates, while θ˜
′
1 and β˜ are conditional
MLE estimates given θˆ0.
Here, we present novel algorithms that substantially reduce the computation burden. Our
algorithms combine recently described univariate LMM tricks [17, 18, 19], with the simultaneous
diagonalization (known as the canonical transformation in animal breeding literatures [10, 53])
for the PX-EM algorithm, and with a few block-diagonal matrix and sparse matrix properties for
the NR algorithm. In effect, our algorithms provide the multivariate analogue of the univariate
algorithms EMMA [14], and FaSTLMM/GEMMA/CM [17, 18, 19]. Specifically, with one O(n3)
operation upfront,
1. The EMMA algorithm reduced the computational cost per iteration for a single univariate
LMM (d = 1) from O(n3) to O(n); in the multivariate case our algorithms reduce O(n3d3)
to O(nd2) for EM and reduce O(n3d7) to O(nd6) for NR .
2. FaSTLMM/GEMMA/CM reduced the computation cost per SNP for univariate LMMs from
O(n3) to O(n2) (or O(n) if K has low rank[17, 39]); in the multivariate case our algorithms
reduce O(n3d3) per SNP to O(n2) (or O(n) if K has low rank).
Our algorithms also obviate the need for the widely used AI algorithm [31] because our imple-
mentation of the NR algorithm has the same time complexity and practical computation time.
For numerical optimization in the null model, we initialize the two variance components to
be both diagonal matrices, with diagonal elements estimated from the corresponding univariate
LMMs. We then perform the PX-EM algorithm, as described in details below, for 10,000 iterations
or until the log likelihood increase between two consecutive iterations is below 10−4. Afterwards,
we perform the NR algorithm, as described in details below, using variance component estimates
from the previous PX-EM algorithm, for another 100 iterations or until the log likelihood increase
between two consecutive iterations is below 10−4. For GWAS applications, for each SNP tested, we
use the variance components estimated from the null model as initial values. Because for moderate d
the PX-EM algorithm is considerably faster than the NR algorithm, we perform the NR algorithm
only for markers where the p value after the PX-EM algorithm is below 1.0 × 10−3. With the
above thresholds, it often takes hundreds to thousands PX-EM iterations followed by a dozen NR
iterations to optimize the null model, and often takes a few dozen PX-EM iterations followed by a
couple NR iterations to optimize the alternative model for each SNP. Notice that all the precision
thresholds and maximal iterations listed above can be adjusted in GEMMA.
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In our experience, both the PX-EM and NR algorithms are required for optimization, consistent
with previous observations (e.g. [31, 32, 30, 29, 4]). On one hand, although the PX-EM algorithm
is stable (each iteration is guaranteed to increase the likelihood), it is often too slow to converge.
For example, in many data sets we have worked on, even thousands of PX-EM iterations may not
be sufficient to maximize the null model (e.g. the difference between the resulting log likelihood
and the true maximal value can be as large as one). And in many GWAS applications, using the
PX-EM algorithm alone will fail to optimize the alternative model in a large fraction of SNPs (an
average of 83% of the p values from the pairwise analyses using PX-EM alone are closer to the
MTMM p values than to the p values obtained by the PX-EM plus NR algorithms in the HMDP
data set; Figure S1). On the other hand, the NR algorithm is fast to converge given a good initial
value (only takes a few iterations), but can easily fail to do so given a bad starting point. Therefore,
we follow previous approaches [31, 32, 30, 29, 4] and combine the two algorithms together, with the
PX-EM algorithm providing a good starting value for the following NR algorithm. In addition, for
moderate d the PX-EM algorithm is considerably faster than the NR algorithm, and so for GWAS
applications, we perform the NR algorithm only for markers where the p value after the PX-EM
algorithm is < 1.0 × 10−3 (or a user adjusted threshold). This strategy makes GWAS analysis a
few times faster than using NR algorithm for every marker, without noticeable loss of accuracy.
1.3 PX-EM Algorithms
Here, we describe an expectation conditional maximization (ECM) algorithm [54] for finding max-
imum likelihood estimates (MLE) in mvLMM, an expectation maximization (EM) algorithm [48]
for finding restricted maximum likelihood estimates (REMLE) in mvLMM, parameter expansion
(PX) versions [49, 50] of the two, and their efficient computations.
1.3.1 An ECM Algorithm for MLE
We view G as missing values, and we have the joint likelihood function as
log l(Y,G|B,Vg,Ve) =
n∑
l=1
{−d log(2pi)− 1
2
log |Ve|− 1
2
log |δlVg|− 1
2
eTl V
−1
e el−
1
2
gTl (δlVg)
−1gl}.
(6)
The conditional distribution of G given Y and the current values of B(t), V
(t)
g , V
(t)
e follows
gl|yl,B(t),V(t)g ,V(t)e ∼ MVN(gˆ(t)l , Σˆ
(t)
l ), (7)
where V
(t)
l = δlV
(t)
g + V
(t)
e , gˆ
(t)
l = δlV
(t)
g (V
(t)
l )
−1(yl −B(t)xl) and Σˆ(t)l = δlV(t)g (V(t)l )−1V(t)e .
The expected value of the log likelihood function, with respect to the conditional distribution
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of G given Y and the current values of B(t), V
(t)
g , V
(t)
e , is
E
G|Y,B(t),V(t)g ,V(t)e [log l(Y,G|B,Vg,Ve)]
=
n∑
l=1
{−d log(2pi)− 1
2
log |δlVg| − 1
2
log |Ve| − 1
2
(yl −Bxl)TV−1e (yl −Bxl)
− 1
2
(gˆ
(t)
l )
T ((δlVg)
−1 + V−1e )
−1gˆ(t)l −
1
2
trace(((δlVg)
−1 + V−1e )
−1Σˆ
(t)
l ) + gˆ
(t)
l V
−1
e (yl −Bxl)}.
(8)
We optimize the above expectation using two conditional maximization steps, in which B(t+1) is
updated conditional on V
(t)
g and V
(t)
e , and V
(t+1)
g , V
(t+1)
e are updated conditional on B(t+1), V
(t)
g
and V
(t)
e , or
B(t+1) = (Y − Gˆ(t))X(XXT )−1, (9)
V(t+1)g =
1
n
n∑
l=1
δ−1l (gˆ
(t)
l (gˆ
(t)
l )
T + Σˆ
(t)
l ), (10)
V(t+1)e =
1
n
n∑
l=1
(eˆ
(t)
l (eˆ
(t)
l )
T + Σˆ
(t)
l ), (11)
where Gˆ(t) is a d by n matrix with lth column gˆ
(t)
l , eˆ
(t)
l = yl − B(t+1)xl − gˆ(t)l . We note that
the derivation of the last two equations requires obtaining the partial derivatives with respect to
vec(Vg) and vec(Ve) based on a few matrix calculus properties listed in [18].
1.3.2 An EM Algorithm for REMLE
We view both B and G as missing values. The joint likelihood function remains the same as in
equation 6, and the joint conditional distribution of B, G given Y and the current values of V
(t)
g ,
V
(t)
e is(
b
g
)
|Y,V(t)g ,V(t)e ∼ MVN(
(
Σˆ
(t)
bb Σˆ
(t)
bg
Σˆ
(t)
gb Σˆ
(t)
gg
)(
(X⊗ (V(t)e )−1)y
(In×n ⊗ (V(t)e )−1)y
)
,
(
Σˆ
(t)
bb Σˆ
(t)
bg
Σˆ
(t)
gb Σˆ
(t)
gg
)
), (12)
where (
Σˆ
(t)
bb Σˆ
(t)
bg
Σˆ
(t)
gb Σˆ
(t)
gg
)
=
(
XXT ⊗ (V(t)e )−1 X⊗ (V(t)e )−1
XT ⊗ (V(t)e )−1 D−1k ⊗ (V(t)g )−1 + In×n ⊗ (V(t)e )−1
)−1
. (13)
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Therefore,
gl|Y,V(t)g ,V(t)e ∼ MVN(gˆ(t)l , Σˆ
(t)
l,gg), (14)
el = yl −Bxl − gl|Y,V(t)g ,V(t)e ∼ MVN(eˆ(t)l , Σˆ
(t)
l,ee), (15)
where
bˆ(t) = Σˆ
(t)
bb
n∑
l=1
xk ⊗ (V(t)l )−1yl, (16)
gˆ
(t)
l =
n∑
l=1
δlV
(t)
g (V
(t)
l )
−1(yl − Bˆ(t)xl), (17)
eˆ
(t)
l = yl − Bˆ(t)xl − gˆ(t)l , (18)
Σˆ
(t)
bb =
n∑
l=1
xlx
T
l ⊗ (V(t)l )−1, (19)
Σˆ
(t)
l,gg = δlV
(t)
g (V
(t)
l )
−1 + (xTl ⊗ δlV(t)g (V(t)l )−1)(
n∑
l=1
xlx
T
l ⊗ δlV(t)g (V(t)l )−1)−1(xl ⊗ δlV(t)g (V(t)l )−1),
(20)
Σˆ
(t)
l,ee = δlV
(t)
g (V
(t)
l )
−1 + (xTl ⊗ (V(t)l )−1)(
n∑
l=1
xlx
T
l ⊗ δlV(t)g (V(t)l )−1)−1(xl ⊗ (V(t)l )−1), (21)
and Bˆ(t) is the matrix satisfies vec(Bˆ(t)) = bˆ(t).
The expected value of the log likelihood function, with respect to the conditional distribution
of B, G given Y and the current values of V
(t)
g , V
(t)
e , is
E
B,G|Y,V(t)g ,V(t)e [log l(Y,G,B|Vg,Ve)]
=
n∑
l=1
{−d log(2pi)− 1
2
log |Ve| − 1
2
log |δlVg| − 1
2
(eˆ
(t)
l )
TV−1e eˆ
(t)
l −
1
2
trace(V−1e Σˆ
(t)
l,ee)
− 1
2
(gˆ
(t)
l )
T (δlVg)
−1gˆ(t)l −
1
2
trace((δlVg)
−1Σˆ
(t)
l,gg)}. (22)
We update V
(t+1)
g and V
(t+1)
e to maximize the above expectation
V(t+1)g =
1
n
n∑
l=1
δ−1l (gˆ
(t)
l (gˆ
(t)
l )
T + Σˆ
(t)
l,gg), (23)
V(t+1)e =
1
n
n∑
l=1
(eˆ
(t)
l (eˆ
(t)
l )
T + Σˆ
(t)
l,ee). (24)
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1.3.3 PX versions of ECM and EM
We introduce a latent parameter Va as a d by d matrix to ensure Vg = VaV
∗
gVa. The mvLMM
with the new parameterization becomes
yl = Bxl + Vag
∗
l + el g
∗
l ∼ MVN(0, δlV∗g) el ∼ MVN(0,Ve), (25)
The expectation of the log likelihood function in the ECM or the EM algorithm is taken at V
(t)
a =
Id×d. The updates for V∗g, Ve (and B for ECM) remain the same, and the update for Va is
V(t+1)a = (
1
n
n∑
l=1
E((yl −Bxl)(g∗l )T ))(
1
n
n∑
l=1
E(g∗l (g
∗
l )
T ))−1. (26)
where the expectations are taken with respect to the conditional distribution of G∗ (and B for EM)
given Y and the current values of V
(t)
g , V
(t)
e (and B(t+1) for ECM).
1.3.4 Efficient computation
The most computationally expensive part of the ECM/EM algorithm is the evaluation of each V−1l
and further the calculation of quantities that involve these inverses. A naive brute force approach
will make the computation cubic in the number of traits, which can be avoided, by performing
a transformation that further converts correlated traits into uncorrelated ones (in addition to the
transformation that we have already performed to convert correlated individuals into uncorrelated
ones). The idea behind this is commonly referred to as the canonical transformation in animal
breeding literatures (e.g. [10, 53] and references there in), or as the simultaneous diagonalization
in linear algebra.
More specifically, for each value of Vg and Ve, we perform an eigen decomposition of the matrix
V
− 1
2
e VgV
− 1
2
e = UλDλU
T
λ , and we transform each phenotype vector yl and each covariate vector
xl by multiplying U
T
λV
− 1
2
e . After that, for each individual, the transformed phenotypes given
the transformed genotypes will follow independent univariate normal distributions (rather than
multivariate normal distributions). Subsequently, each V−1l = V
− 1
2
e Uλ(Dλ + Id×d)−1UTλV
− 1
2
e and
quantities involving V−1l can be calculated efficiently.
Therefore, the computation complexity for each iteration in the (PX) ECM/EM algorithm is
O(nc2d2).
1.4 Newton-Raphson’s Algorithms
Here, we describe Newton-Raphson’s algorithms for MLE and REMLE estimation in mvLMM.
Although an average-information algorithm [31] has often been used in place of a standard Newton-
Raphson’s algorithm, we found it unnecessary when we use the efficient algorithms described below.
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1.4.1 Target functions and partial derivatives
Both the log-likelihood function and the log-restricted likelihood function can be expressed as
functions for Vg and Ve only:
l(Vg,Ve) = −nd
2
log(2pi)− 1
2
log |H| − 1
2
yTPy, (27)
lr(Vg,Ve) = −(n− c− 1)d
2
log(2pi) +
d
2
log |XXT | − 1
2
log |H|
− 1
2
log |(X⊗ Id×d)H−1(XT ⊗ Id×d)| − 1
2
yTPy, (28)
where
H = Dk ⊗Vg + In×n ⊗Ve = diag(Vl), (29)
P = H−1 −H−1(XT ⊗ Id×d)((X⊗ Id×d)H−1(XT ⊗ Id×d))−1(X⊗ Id×d)H−1. (30)
With a slight abuse of notation, we denote vg,ij as the ijth element of Vg, ve,ij as the ijth element
of Ve, Ii as a d-vector with ith element 1 and other elements 0, and Iij = IiI
T
j as a d by d matrix
with ijth element 1 and other elements 0. We have
∂vec(Dk ⊗Vg)
∂vg,ij
= vec(Dk ⊗ (Iij + Iji)) 1
1 + 1i=j
, (31)
∂vec(In×n ⊗Ve)
∂ve,ij
= vec(In×n ⊗ (Iij + Iji)) 1
1 + 1i=j
, (32)
where 1i=j is an indicator function that takes value 1 when i equals j and 0 otherwise.
With a few matrix calculus properties listed in [18], we obtain the first order partial derivatives
for the log-likelihood and the log-restricted likelihood functions
∂l
∂vg,ij
=
1
1 + 1i=j
{−1
2
trace(H−1(Dk ⊗ (Iij + Iji))) + 1
2
yTP(Dk ⊗ (Iij + Iji))Py}, (33)
∂l
∂ve,ij
=
1
1 + 1i=j
{−1
2
trace(H−1(In×n ⊗ (Iij + Iji))) + 1
2
yTP(In×n ⊗ (Iij + Iji))Py}, (34)
∂lr
∂vg,ij
=
1
1 + 1i=j
{−1
2
trace(P(Dk ⊗ (Iij + Iji))) + 1
2
yTP(Dk ⊗ (Iij + Iji))Py}, (35)
∂lr
∂ve,ij
=
1
1 + 1i=j
{−1
2
trace(P(In×n ⊗ (Iij + Iji))) + 1
2
yTP(In×n ⊗ (Iij + Iji))Py}, (36)
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and the second order partial derivatives for the log-likelihood function
∂l2
∂vg,ij∂vg,i′j′
=
1
(1 + 1i=j)(1 + 1i′=j′)
{1
2
trace(H−1(Dk ⊗ (Iij + Iji))H−1(Dk ⊗ (Ii′j′ + Ij′i′)))
− yTP(Dk ⊗ (Iij + Iji))P(Dk ⊗ (Ii′j′ + Ij′i′))Py}, (37)
∂l2
∂vg,ij∂ve,i′j′
=
1
(1 + 1i=j)(1 + 1i′=j′)
{1
2
trace(H−1(Dk ⊗ (Iij + Iji))H−1(In×n ⊗ (Ii′j′ + Ij′i′)))
− yTP(Dk ⊗ (Iij + Iji))P(In×n ⊗ (Ii′j′ + Ij′i′))Py}, (38)
∂l2
∂ve,ij∂ve,i′j′
=
1
(1 + 1i=j)(1 + 1i′=j′)
{1
2
trace(H−1(In×n ⊗ (Iij + Iji))H−1(In×n ⊗ (Ii′j′ + Ij′i′)))
− yTP(In×n ⊗ (Iij + Iji))P(In×n ⊗ (Ii′j′ + Ij′i′))Py}, (39)
and second order partial derivatives for the log-restricted likelihood function
∂l2r
∂vg,ij∂vg,i′j′
=
1
(1 + 1i=j)(1 + 1i′=j′)
{1
2
trace(P(Dk ⊗ (Iij + Iji))P(Dk ⊗ (Ii′j′ + Ij′i′)))
− yTP(Dk ⊗ (Iij + Iji))P(Dk ⊗ (Ii′j′ + Ij′i′))Py}, (40)
∂l2r
∂vg,ij∂ve,i′j′
=
1
(1 + 1i=j)(1 + 1i′=j′)
{1
2
trace(P(Dk ⊗ (Iij + Iji))P(In×n ⊗ (Ii′j′ + Ij′i′)))
− yTP(Dk ⊗ (Iij + Iji))P(In×n ⊗ (Ii′j′ + Ij′i′))Py}, (41)
∂l2r
∂ve,ij∂ve,i′j′
=
1
(1 + 1i=j)(1 + 1i′=j′)
{1
2
trace(P(In×n ⊗ (Iij + Iji))P(In×n ⊗ (Ii′j′ + Ij′i′)))
− yTP(In×n ⊗ (Iij + Iji))P(In×n ⊗ (Ii′j′ + Ij′i′))Py}. (42)
1.4.2 Efficient computation
We describe in this section the efficient calculations of the target functions, the first-order partial
derivatives with respect to vg,ij , and the second-order partial derivatives with respect to vg,ij and
vg,i′j′ . The first-order and second-order partial derivatives with respect to other parameters can
be calculated in a similar fashion. The calculations described here use basic properties of block
diagonal matrices and sparse matrices.
We denote Q = (X ⊗ Id×d)H−1(XT ⊗ Id×d), q = (X ⊗ Id×d)H−1y, q = yTH−1y, and with a
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slight abuse of notation, denote
Qgij = (X⊗ Id×d)H−1(Dk ⊗ Iij)H−1(XT ⊗ Id×d), (43)
qgij = (X⊗ Id×d)H−1(Dk ⊗ Iij)H−1y, (44)
qgij = y
TH−1(Dk ⊗ Iij)H−1y, (45)
Qggij,i′j′ = (X⊗ Id×d)H−1(Dk ⊗ Iij)H−1(Dk ⊗ Ii′j′)H−1(XT ⊗ Id×d), (46)
qggij,i′j′ = (X⊗ Id×d)H−1(Dk ⊗ Iij)H−1(Dk ⊗ Ii′j′)H−1y, (47)
qggij,i′j′ = y
TH−1(Dk ⊗ Iij)H−1(Dk ⊗ Ii′j′)H−1y. (48)
For the trace terms, we have
trace(P(Dk ⊗ Iij)) = trace(H−1(Dk ⊗ Iij))− trace(Q−1Qgij), (49)
trace(P(Dk ⊗ Iij)P(Dk ⊗ Ii′j′)) = trace(H−1(Dk ⊗ Iij)H−1(Dk ⊗ Ii′j′))
− trace(Q−1Qggij,i′j′)− trace(Q−1Qggi′j′,ij) + trace(Q−1QgijQ−1Qgi′j′). (50)
For the vector-matrix-vector product terms, we have
yTPy =q − qTQ−1q, (51)
yTP(Dk ⊗ Iij)Py = qgij − qTQ−1qgij − (qgij)TQ−1q + qTQ−1QgijQ−1q, (52)
yTP(Dk ⊗ Iij)P(Dk ⊗ Ii′j′)Py = qggij,i′j′ − qTQ−1qggij,i′j′ − (qggj′i′,ji)TQ−1q− (qgji)TQ−1qgi′j′
+ qTQ−1QgijQ
−1qgi′j′ + (q
g
ji)
TQ−1Qgi′j′Q
−1q + qTQ−1Qggij,i′j′q
− qTQ−1QgijQ−1Qgi′j′Q−1q. (53)
Therefore, it suffices to efficiently evaluate
|H| =
n∑
l=1
|Vl|, (54)
trace(H−1(Dk ⊗ Iij)) =
n∑
l=1
δl(I
T
j V
−1
l Ii), (55)
trace(H−1(Dk ⊗ Iij)H−1(Dk ⊗ Ii′j′)) =
n∑
l=1
δ2l (I
T
j′V
−1
l Ii)(I
T
j V
−1
l Ii′), (56)
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and
Q =
n∑
l=1
(xlx
T
l )⊗V−1l , (57)
q =
n∑
l=1
xl ⊗ (V−1l yl), (58)
q =
n∑
l=1
yTl V
−1
l yl, (59)
and
Qgij =
n∑
l=1
δl(xlx
T
l )⊗ (V−1l IijV−1l ), (60)
qgij =
n∑
l=1
δlxl ⊗ (V−1l IijV−1l yl), (61)
qgij =
n∑
l=1
δly
T
l V
−1
l IijV
−1
l yl, (62)
Qggij,i′j′ =
n∑
l=1
δ2l (xlx
T
l )⊗ (V−1l IijV−1l Ii′j′V−1l ), (63)
qggij,i′j′ =
n∑
l=1
δ2l xl ⊗ (V−1l IijV−1l Ii′j′V−1l yl), (64)
qggij,i′j′ =
n∑
l=1
δ2l y
T
l V
−1
l IijV
−1
l Ii′j′V
−1
l yl. (65)
Notice that one key trick for calculating all the above quantities is observing that Iij = IiI
T
j . In this
way, many of the above quantities only involve scalar multiplications or rank one matrix updates.
The most time consuming part is the calculation of Qggij,i′j′ , each requiring O(nc
2d2) computa-
tion time. The computation complexity for each iteration in the Newton-Raphson’s algorithm is
therefore O(nc2d6).
1.5 Test Statistics and p Values
1.5.1 Test Statistics
We consider three common tests for mvLMMs: the likelihood ratio test, the Wald test and the
score test.
The likelihood ratio test calculates the maximum log likelihoods for both the alternative (lˆ1(Vˆg,1, Vˆe,1))
and the null (lˆ0(Vˆg,0, Vˆe,0)) models. It computes a test statistics based on the difference between
the two: zLR = 2(lˆ1(Vˆg,1, Vˆe,1)− lˆ1(Vˆg,0, Vˆe,0)).
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The Wald estimates the effect size
βˆ =
n∑
l=1
xlVˆ
−1
l yl − (
n∑
l=1
(xlwl)⊗ Vˆ−1l )(
n∑
l=1
(wlw
T
l )⊗ Vˆ−1l )−1(
n∑
l=1
wl ⊗ (Vˆ−1l yl)), (66)
and its precision V (βˆ)−1
V (βˆ)−1 =
n∑
l=1
x2l Vˆ
−1
l − (
n∑
l=1
(xlwl)⊗ Vˆ−1l )(
n∑
l=1
(wlw
T
l )⊗ Vˆ−1l )−1(
n∑
l=1
(xlwl)⊗ Vˆ−1l ), (67)
with the variance component estimates Vˆg and Vˆe (Vˆl = δlVˆg,1 + Vˆe,1) obtained under the
alternative. Above, xl is the lth element of the transformed genotype vector x and wl is the
lth column vector of the transformed covariance matrix W. Afterwards, it computes zWald =√
βˆ
T
V (βˆ)−1βˆ.
The score test computes the score, a d(d + 1) vector sˆ, with each element equals to the cor-
responding first order partial derivate described in the previous sections, and the observed infor-
mation matrix, a d(d + 1) by d(d + 1) matrix Iˆ, whose formula is also described above. These
values are evaluated with parameter estimates obtained under the null, and are used to compute
zScore =
√
sˆT Iˆ−1sˆ.
1.5.2 p Value Calibration
Under the null hypothesis, all three test statistics follow a χ2(d) distribution asymptotically. How-
ever, when the sample size is small or the relatedness structure is strong, then the test statistics
will not follow the asymptotic distribution exactly, and p values calculated from the asymptotic
distribution will not be be calibrated (see, e.g. [55, 56]). To correct for this, we follow [56] and use
Edgeworth-corrected critical values for the three tests. Specifically, the corrected z scores from the
three tests for a given marker is
zcLR = zLR/(1 +
aˆ
2d
), (68)
zcWald =
−(2d+ aˆ+ bˆ)(d+ 2) +
√
(2d+ aˆ+ bˆ)2(d+ 2)2 + 8d(d+ 2)cˆzWald
2cˆ
, (69)
zcScore =
(2d+ aˆ− bˆ)(d+ 2)−
√
(2d+ aˆ− bˆ)2(d+ 2)2 − 8d(d+ 2)cˆzScore
2cˆ
, (70)
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where
aˆ = 2bˆ− cˆ, (71)
bˆ = 2
∑
i<j
∑
i′<j′
Λˆij,i′j′trace((RQˆ
−1Qˆij,i′j′Qˆ−1RT −RQˆ−1QˆijQˆ−1Qˆi′j′Qˆ−1RT )(RQˆ−1RT )−1),
(72)
cˆ =
∑
i<j
∑
i′<j′
Λˆij,i′j′(trace((RQˆ
−1QˆijQˆ−1RT )(RQˆ−1RT )−1(RQˆ−1Qˆi′j′Qˆ−1RT )(RQˆ−1RT )−1),
+
1
2
trace((RQˆ−1QˆijQˆ−1RT )(RQˆ−1RT )−1)trace((RQˆ−1Qˆi′j′Qˆ−1RT )(RQˆ−1RT )−1)) (73)
are evaluated with the variance component estimates from the alternative model. Λ is the inverse
of the Hessian matrix and Λij is its ijth element, and R is a d by cd matrix with right most d by
d matrix a diagonal matrix and all other elements 0.
Notice that the corrections are marker-specific, and require estimates and partial derivatives
from the alternative model. In our experience, without the corrections, the score test is often too
conservative, the Wald test is often too anti-conservative, while the likelihood ratio test behaves
between the two and has the correct control for type I error.
1.6 Phenotype Imputation
The tricks used in our mvLMM algorithms require complete or imputed phenotypes. Although
for many studies fully observed phenotypes will be collected for all individuals, it is possible that
in some cases, some individuals may have one or more phenotypes missing. To fully harness the
information in these situiations and to avoid dropping individuals with partially missing phenotypes,
we present a method to impute missing phenotypes before association tests.
Specifically, we first estimate bˆ, Vˆg and Vˆe in the null model using individuals with completely
observed phenotypes. Afterwards, we impute missing phenotype values using the conditional mean
given observed phenotypes and estimated parameters. Denote no as the number of observed values,
nm as the number of missing values (no + nm = nd), yo as a no vector of observed values and Xo
as a no by dc matrix of corresponding covariates, ym as a nm vector of missing values and Xm as
a nm by dc matrix of corresponding covariates. Under the null mvLMM, y = [y
T
o ,y
T
m]
T follows a
multivariate normal distribution with covariance matrix Hˆ = K ⊗ Vˆg + I ⊗ Vˆe. Let Hˆoo be the
no by no sub-matrix of H that corresponds to the no observed values, and Hˆmo be the nm by no
sub-matrix of Hˆ that corresponds to the nm missing values and no observed values. We use the
conditional mean of ym given yo and estimated parameters as an estimate for the missing values
yˆm = X
T
mbˆ + HˆmoHˆ
−1
oo (yo −XTo bˆ). (74)
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2 Supplementary Results
Figure S1: Comparison of -log10 p values obtained from GEMMA using both PX-EM and NR, with
those from MTMM (black) or those from GEMMA using only PX-EM (red), for all paired traits
in the HMDP data set.
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(a) HMDP-based simulations (b) NFBC1966-based simulations
(c) HMDP-based simulations (d) NFBC1966-based simulations
Figure S2: Power comparison between the four-phenotype analysis and the two-phenotype analysis
with GEMMA, using simulations based on the HMDP data (a, c) or the NFBC1966 data (b, d). x-
axis shows the proportion of phenotypic variance in the affected traits explained (PVE) by the SNP.
Symbol size and line type indicate the number of phenotypes affected by the causal SNP. For four-
phenotype analysis (red), the genome-wide significance threshold after Bonferroni correction for the
number of SNPs is used (4.6 × 10−7 for HMDP-based simulations and 1.6 × 10−7 for NFBC1966-
based simulations). For two-phenotype analysis, either the same genome-wide significance threshold
is used (black) (c, d), or a significance threshold further corrected for the six tests performed by
the two-trait analysis (7.6×10−8 for HMDP-based simulations and 2.6×10−8 for NFBC1966-based
simulations) is used (blue) (a, b).
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(a) Imputation vs Dropping (HMDP) (b) Imputation vs Dropping (NFBC1966)
Figure S3: Power comparison of the two approaches to deal with missing phenotypes in GEMMA,
using simulations based on the HMDP data (a) or the NFBC1966 data (b). The first approach use
only individuals with fully observed phenotypes (dropping, blue). The second approach imputes
phenotypes before association tests (imputation, red). x-axis shows the percentage of individuals
having one missing phenotype. the point symbol and line type indicate the SNP effect direction
(compared with its effect on the first phenotype) and size (quantified by PVE) on the second
phenotype (+: opposite direction, 0.8PVE; ×: opposite direction, 0.2PVE; o: same direction,
0.8PVE; ∆: same direction, 0.2PVE).
28
Table S1: List of SNPs that exceed the significance of 0.05 after Bonferroni correction for both
the number of SNPs and the number of tests from either the four-phenotype mvLMM analysis
or the univariate LMM analysis in the NFBC1966 data set. λGC is the genomic control inflation
factor. p values in the four-phenotype analysis below the threshold (1.6 × 10−7), and p values in
the univariate analysis below the threshold (3.9× 10−8) are in bold font. SNPs that are significant
only in the four-phenotype analysis but not in the univariate analysis are highlighted in red, while
SNPs that are significant only in the univariate analysis are highlighted in blue. SNPs that are
more significant in the four-phenotype analysis than in the univariate analysis (after correcting for
the number of tests performed) are highlighted in magenta (in addition to red).
SNP Position
mvLMM (p value) LMM (p value)
Four Traits HDL LDL TG CRP
(λGC = 0.979) (λGC = 0.998) (λGC = 1.003) (λGC = 1.000) (λGC = 0.993)
CELSR2 chromosome 1
rs646776 109620053 1.54× 10−16 9.17× 10−12 1.23× 10−15 9.30× 10−1 6.32× 10−2
CRP chromosome 1
rs1811472 157908973 1.19× 10−13 7.05× 10−2 8.81× 10−1 4.90× 10−1 1.42× 10−15
rs12093699 157914612 4.71× 10−12 8.75× 10−1 5.77× 10−1 8.39× 10−1 3.39× 10−13
rs2592887 157919563 8.79× 10−16 4.99× 10−2 9.34× 10−1 3.17× 10−1 5.13× 10−18
rs2794520 157945440 9.29× 10−21 2.98× 10−1 7.34× 10−1 9.91× 10−1 2.84× 10−22
rs11265260 157966663 2.27× 10−10 5.85× 10−2 1.55× 10−1 6.90× 10−1 6.28× 10−11
APOB chromosome 2
rs6728178 21047434 7.37× 10−9 3.46× 10−6 7.57× 10−7 3.29× 10−6 3.62× 10−1
rs6754295 21059688 7.99× 10−9 3.83× 10−6 6.27× 10−7 5.25× 10−6 3.48× 10−1
rs676210 21085029 2.09× 10−8 2.74× 10−6 8.01× 10−6 1.79× 10−6 4.65× 10−1
rs693 21085700 9.50× 10−8 4.19× 10−2 1.05× 10−9 4.00× 10−3 3.48× 10−1
rs673548 21091049 1.36× 10−8 2.19× 10−6 6.71× 10−6 1.32× 10−6 4.79× 10−1
rs1429974 21154275 6.33× 10−7 8.02× 10−2 1.65× 10−8 1.84× 10−1 9.48× 10−1
rs754524 21165046 2.44× 10−8 9.44× 10−2 7.82× 10−10 1.57× 10−1 6.10× 10−1
rs754523 21165196 5.68× 10−7 8.55× 10−2 1.55× 10−8 1.93× 10−1 9.66× 10−1
GCKR chromosome 2
rs1260326 27584444 1.16× 10−8 1.58× 10−1 1.14× 10−1 2.21× 10−10 5.25× 10−2
rs780094 27594741 1.02× 10−7 3.38× 10−1 2.63× 10−1 3.50× 10−9 1.44× 10−1
PPP1R3B chromosome 8
rs983309 9215142 6.40× 10−9 5.99× 10−5 2.57× 10−3 7.57× 10−1 1.55× 10−3
rs2126259 9222556 1.19× 10−9 1.67× 10−5 5.79× 10−4 4.24× 10−1 5.93× 10−3
LPL chromosome 8
rs10096633 19875201 8.96× 10−10 8.23× 10−7 9.36× 10−1 1.01× 10−8 5.22× 10−1
FADS chromosome 11
rs174537 61309256 5.55× 10−8 3.41× 10−2 3.76× 10−6 2.45× 10−2 8.44× 10−1
rs102275 61314379 3.25× 10−8 2.22× 10−2 3.06× 10−6 2.27× 10−2 9.05× 10−1
rs174546 61326406 2.80× 10−8 3.99× 10−2 2.25× 10−6 2.03× 10−2 9.04× 10−1
rs174556 61337211 6.88× 10−8 1.67× 10−1 7.02× 10−7 5.44× 10−2 9.89× 10−1
rs1535 61354548 9.40× 10−8 4.76× 10−2 4.11× 10−6 2.77× 10−2 8.71× 10−1
HNF1A chromosome 12
rs2650000 119873345 1.48× 10−10 2.16× 10−1 9.36× 10−1 6.48× 10−1 1.44× 10−12
rs7953249 119888107 2.21× 10−10 1.43× 10−1 9.16× 10−1 6.10× 10−1 2.38× 10−12
rs1169300 119915608 5.29× 10−8 6.76× 10−1 4.05× 10−1 5.27× 10−1 4.28× 10−9
rs2464196 119919810 5.82× 10−8 5.95× 10−1 5.44× 10−1 5.74× 10−1 3.58× 10−9
rs735396 119923227 1.19× 10−7 7.17× 10−1 3.22× 10−1 3.18× 10−1 2.24× 10−8
LIPC chromosome 15
rs166358 56468097 3.66× 10−10 8.57× 10−8 3.80× 10−2 2.29× 10−1 5.43× 10−1
rs1532085 56470658 2.52× 10−16 8.33× 10−13 3.46× 10−1 6.05× 10−2 6.21× 10−1
rs415799 56478046 7.47× 10−10 2.32× 10−8 5.72× 10−1 1.13× 10−1 9.06× 10−1
rs16940213 56482629 5.51× 10−8 3.19× 10−6 2.67× 10−1 1.31× 10−1 4.29× 10−1
rs473224 56524633 6.54× 10−9 1.57× 10−3 5.30× 10−1 7.64× 10−5 1.73× 10−1
rs261336 56529710 2.29× 10−9 6.51× 10−4 2.30× 10−1 7.08× 10−5 3.00× 10−1
CETP chromosome 16
rs9989419 55542640 1.88× 10−9 5.79× 10−10 7.63× 10−1 9.62× 10−1 6.12× 10−1
rs3764261 55550825 1.85× 10−38 6.56× 10−37 7.09× 10−2 2.52× 10−1 2.06× 10−1
rs1532624 55562980 1.30× 10−26 3.15× 10−27 1.64× 10−1 1.20× 10−1 1.05× 10−1
rs7499892 55564091 4.01× 10−22 9.93× 10−20 8.36× 10−1 4.51× 10−1 8.09× 10−1
LCAT chromosome 16
rs255049 66570972 5.34× 10−8 6.86× 10−9 1.44× 10−1 1.60× 10−1 7.50× 10−1
rs255052 66582496 9.72× 10−8 5.98× 10−9 2.01× 10−1 2.36× 10−1 7.02× 10−1
LDLR chromosome 19
rs11668477 11056030 1.09× 10−6 5.95× 10−2 2.04× 10−8 1.66× 10−2 7.18× 10−1
APO cluster chromosome 19
rs157580 50087106 1.51× 10−8 9.82× 10−3 1.06× 10−8 1.18× 10−3 2.42× 10−1
rs2075650 50087459 1.21× 10−12 4.95× 10−2 8.54× 10−6 2.20× 10−5 1.01× 10−5
HNF4A chromosome 20
rs1800961 42475778 1.21× 10−7 1.15× 10−8 3.78× 10−1 4.59× 10−3 4.99× 10−1
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Table S2: List of SNPs that exceed the significance of 0.05 after Bonferroni correction for both the
number of SNPs and the number of tests from either the four-phenotype mvLMM analysis or the
two-phenotype mvLMM analysis in the NFBC1966 data set. λGC is the genomic control inflation
factor. p values in the four-phenotype analysis below the threshold (1.6×10−7), and p values in the
two-phenotype analysis below the threshold (2.6×10−8) are in bold font. SNPs that are significant
only in the four-phenotype analysis but not in the two-phenotype analysis are highlighted in red.
No SNP is significant only in the two-phenotype analysis. SNPs that are more significant in the
four-phenotype analysis than in the two-phenotype analysis (after correcting for the number of
tests performed) are highlighted in magenta (in addition to red).
SNP Position
mvLMM (p value)
Four Traits HDL-LDL HDL-TG HDL-CRP LDL-TG LDL-CRP TG-CRP
(λGC = 0.979) (λGC = 0.989) (λGC = 0.991) (λGC = 0.992) (λGC = 0.993) (λGC = 0.998) (λGC = 0.994)
CELSR2 chromosome 1
rs646776 109620053 1.54× 10−16 1.1× 10−14 1.98× 10−1 1.92× 10−2 3.06× 10−16 3.84× 10−16 1.61× 10−1
CRP chromosome 1
rs1811472 157908973 1.19× 10−13 1.82× 10−1 2.04× 10−1 9.17× 10−15 7.18× 10−1 9.23× 10−15 7.87× 10−15
rs12093699 157914612 4.71× 10−12 8.28× 10−1 9.70× 10−1 3.82× 10−13 7.99× 10−1 3.17× 10−12 5.40× 10−13
rs2592887 157919563 8.79× 10−16 1.45× 10−1 1.49× 10−1 4.24× 10−17 5.80× 10−1 4.12× 10−17 3.97× 10−17
rs2794520 157945440 9.29× 10−21 5.20× 10−1 5.34× 10−1 1.77× 10−21 9.31× 10−1 1.47× 10−21 2.82× 10−22
rs11265260 157966663 2.27× 10−10 3.98× 10−2 7.62× 10−2 5.11× 10−10 3.68× 10−1 5.94× 10−11 6.07× 10−11
APOB chromosome 2
rs6728178 21047434 7.37× 10−9 1.48× 10−9 2.03× 10−7 2.63× 10−5 3.02× 10−8 4.92× 10−6 2.23× 10−5
rs6754295 21059688 7.99× 10−9 1.37× 10−9 2.98× 10−7 2.78× 10−5 3.61× 10−8 4.01× 10−6 3.40× 10−5
rs676210 21085029 2.09× 10−8 9.04× 10−9 1.11× 10−7 2.03× 10−5 1.07× 10−7 4.91× 10−5 1.18× 10−5
rs693 21085700 9.50× 10−8 3.95× 10−9 9.83× 10−3 1.26× 10−1 5.94× 10−9 9.09× 10−9 1.81× 10−2
rs673548 21091049 1.36× 10−8 6.45× 10−9 7.78× 10−8 1.64× 10−5 7.52× 10−8 4.18× 10−5 8.73× 10−6
rs754524 21165046 2.44× 10−8 4.15× 10−9 1.79× 10−1 1.63× 10−1 4.90× 10−9 3.01× 10−9 2.46× 10−1
GCKR chromosome 2
rs1260326 27584444 1.16× 10−8 1.38× 10−1 9.00× 10−10 8.54× 10−2 1.51× 10−9 5.77× 10−2 1.36× 10−9
rs780094 27594741 1.02× 10−7 3.83× 10−1 9.08× 10−9 2.61× 10−1 1.82× 10−8 2.11× 10−1 2.23× 10−8
PPP1R3B chromosome 8
rs983309 9215142 6.40× 10−9 5.04× 10−7 1.24× 10−4 7.54× 10−8 3.98× 10−3 1.71× 10−4 3.30× 10−3
rs2126259 9222556 1.19× 10−9 2.41× 10−8 6.04× 10−5 1.02× 10−7 3.11× 10−4 1.46× 10−4 6.95× 10−3
LPL chromosome 8
rs10096633 19875201 8.96× 10−10 4.38× 10−6 1.10× 10−9 2.53× 10−6 1.20× 10−8 8.12× 10−1 3.01× 10−8
FADS chromosome 11
rs174537 61309256 5.55× 10−8 5.10× 10−7 3.43× 10−2 8.73× 10−2 8.47× 10−9 2.32× 10−5 5.96× 10−2
rs102275 61314379 3.25× 10−8 2.54× 10−7 2.51× 10−2 6.23× 10−2 5.90× 10−9 1.85× 10−5 5.91× 10−2
rs174546 61326406 2.80× 10−8 3.6× 10−7 3.32× 10−2 1.06× 10−1 3.35× 10−9 1.38× 10−5 5.34× 10−2
rs174556 61337211 6.88× 10−8 5.58× 10−7 1.32× 10−1 3.84× 10−1 4.08× 10−9 4.04× 10−6 1.45× 10−1
rs1535 61354548 9.40× 10−8 8.18× 10−7 4.48× 10−2 1.21× 10−1 1.18× 10−8 2.50× 10−5 6.91× 10−2
HNF1A chromosome 12
rs2650000 119873345 1.48× 10−10 4.54× 10−1 4.53× 10−1 1.67× 10−11 8.76× 10−1 1.02× 10−11 4.90× 10−12
rs7953249 119888107 2.21× 10−10 3.31× 10−1 3.35× 10−1 2.45× 10−11 8.41× 10−1 1.67× 10−11 9.40× 10−12
rs1169300 119915608 5.29× 10−8 6.16× 10−1 6.20× 10−1 2.55× 10−8 6.81× 10−1 1.26× 10−8 3.13× 10−9
rs2464196 119919810 5.82× 10−8 6.90× 10−1 5.99× 10−1 2.31× 10−8 7.92× 10−1 1.44× 10−8 3.05× 10−9
rs735396 119923227 1.19× 10−7 5.45× 10−1 4.23× 10−1 1.17× 10−7 4.96× 10−1 5.24× 10−8 8.3× 10−9
LIPC chromosome 15
rs166358 56468097 3.66× 10−10 2.34× 10−7 8.28× 10−10 1.39× 10−7 1.58× 10−2 8.50× 10−2 4.45× 10−1
rs1532085 56470658 2.52× 10−16 1.21× 10−12 1.06× 10−17 1.21× 10−12 1.67× 10−1 5.87× 10−1 1.63× 10−1
rs415799 56478046 7.47× 10−10 7.02× 10−8 2.87× 10−11 1.03× 10−7 2.90× 10−1 8.39× 10−1 2.39× 10−1
rs16940213 56482629 5.51× 10−8 1.71× 10−5 2.37× 10−8 3.84× 10−6 7.46× 10−2 3.62× 10−1 2.85× 10−1
rs473224 56524633 6.54× 10−9 3.80× 10−3 7.00× 10−10 9.57× 10−4 3.09× 10−4 3.47× 10−1 2.80× 10−4
rs261336 56529710 2.29× 10−9 7.29× 10−4 1.33× 10−10 6.20× 10−4 3.68× 10−4 3.19× 10−1 3.35× 10−4
CETP chromosome 16
rs9989419 55542640 1.88× 10−9 4.05× 10−9 9.67× 10−11 2.94× 10−9 9.21× 10−1 8.41× 10−1 8.43× 10−1
rs3764261 55550825 1.85× 10−38 1.06× 10−35 1.19× 10−39 2.19× 10−36 1.64× 10−1 1.07× 10−1 3.02× 10−1
rs1532624 55562980 1.30× 10−26 4.42× 10−26 4.79× 10−28 2.04× 10−26 1.89× 10−1 1.25× 10−1 1.22× 10−1
rs7499892 55564091 4.01× 10−22 3.88× 10−19 1.13× 10−23 2.25× 10−19 7.52× 10−1 9.44× 10−1 6.62× 10−1
LCAT chromosome 16
rs255049 66570972 5.34× 10−8 4.07× 10−9 3.25× 10−8 2.85× 10−8 4.75× 10−2 3.29× 10−1 3.32× 10−1
rs255052 66582496 9.72× 10−8 5.24× 10−9 2.10× 10−8 4.58× 10−8 1.06× 10−1 3.81× 10−1 5.12× 10−1
APO cluster chromosome 19
rs157580 50087106 1.51× 10−8 1.42× 10−8 1.95× 10−3 7.83× 10−3 2.57× 10−8 1.60× 10−8 7.35× 10−4
rs2075650 50087459 1.21× 10−12 1.93× 10−5 1.17× 10−4 7.21× 10−7 6.24× 10−7 2.88× 10−10 2.27× 10−11
HNF4A chromosome 20
rs1800961 42475778 1.21× 10−7 8.41× 10−8 7.61× 10−8 1.05× 10−8 1.81× 10−2 5.05× 10−1 6.03× 10−3
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